<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03921931</url>
  </required_header>
  <id_info>
    <org_study_id>OPHT-050418</org_study_id>
    <nct_id>NCT03921931</nct_id>
  </id_info>
  <brief_title>Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study</brief_title>
  <official_title>Assessment of Retinal Photoreceptor Outer Segment Length With Optical Coherence Tomography Before and After Light Stimulation - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been shown that reactions of human retinal photoreceptors to a light stimulus can be
      measured with custom-made, research prototype optical coherence tomography (OCT) systems.
      This can be used as a biomarker for the function of the photoreceptors. Due to the high
      technical demands on the system, however, the technique is currently not available for
      clinical purposes. In this pilot study a protocol to measure changes in retinal photoreceptor
      layer thickness before and after light stimulation shall be developed based on a commercial
      OCT system and newly developed algorithms. Other variables, such as circadian processes shall
      be investigated as well. After measurements in healthy volunteers, the protocol is planned to
      be applied in patients with primary open angle glaucoma (POAG) and age-related macular
      degeneration (AMD) to test for feasibility of the method in these patient groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Light stimulation</measure>
    <time_frame>1 day</time_frame>
    <description>Optical path length changes between inner segment outer segment junction and retinal pigment epithelium (RPE) will be measured with OCT in 15 healthy volunteers, 10 POAG patients and 10 AMD patients before and after light stimulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Light stimulation of contralateral eye</measure>
    <time_frame>1 day</time_frame>
    <description>Optical path length changes between inner segment outer segment junction and retinal pigment epithelium (RPE) will be measured with OCT in 15 healthy volunteers, 10 POAG patients and 10 AMD patients before and after light stimulation in the contralateral eye</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in photoreceptor layer thickness over the course of 8 hours</measure>
    <time_frame>8 hours</time_frame>
    <description>Influence of circadian rhythm on the length of retinal photoreceptor outer segments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>En face maps</measure>
    <time_frame>1 day</time_frame>
    <description>test an algorithm for production of en face maps of retinal photoreceptor outer segment length</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Macular Degeneration, Dry</condition>
  <condition>Primary Open-angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>light stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>primary open angle glaucoma patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>light stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>age-related macular degeneration patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>light stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>White light stimulation</intervention_name>
    <description>Stimulation of the retina with white light</description>
    <arm_group_label>age-related macular degeneration patients</arm_group_label>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_label>primary open angle glaucoma patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women aged over 18 years

          -  signed informed consent form

          -  ametropia below 3 diopters

          -  ability and willingness to follow instructions

        for healthy volunteers:

          -  normal ophthalmologic findings

        for primary open angle glaucoma patients (POAG):

          -  diagnosed POAG

          -  MD &lt;= 10 dB

        for age-related macular degeneration (AMD):

          -  diagnosed dry AMD

          -  diagnosed stage II or stage III AMD

        Exclusion Criteria:

          -  Presence of any abnormalities preventing reliable measurements

          -  Ocular inflammation and ocular disease interfering with the study aims

          -  Use of photosensitizing medication (phototoxic drugs, photoallergic drugs) in the 3
             months preceding the study

          -  Presence of any condition with the possibility of causing photosensitivity, including
             systemic lupus erythematosus SLE, Porphyria, Vitiligo, Xeroderma Pigmentosum and
             Albinism

          -  Presence of any form of epilepsy

          -  Ocular surgery in the 3 months preceding the study

          -  Pregnancy, planned pregnancy or lactating

          -  Any medical or surgical history, disorder or disease such as acute or chronic severe
             organic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Doreen Schmidl, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Pharmacology, Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Doreen Schmidl, MD,PhD</last_name>
    <phone>0043140400</phone>
    <phone_ext>29810</phone_ext>
    <email>doreen.schmidl@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Vienna, Department of Clinical Pharmacology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doreen Schmidl, MD, PhD</last_name>
      <phone>0043140400</phone>
      <phone_ext>29810</phone_ext>
      <email>doreen.schmidl@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Doreen Schmidl, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alina Messner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 4, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Doreen Schmidl</investigator_full_name>
    <investigator_title>Associate Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>light stimulation</keyword>
  <keyword>retinal photoreceptors</keyword>
  <keyword>light adaptation</keyword>
  <keyword>functional optical coherence tomography</keyword>
  <keyword>optophysiology</keyword>
  <keyword>intrinsic optical signals</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Geographic Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

